Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05545241
Other study ID # 2022/718
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 15, 2022
Est. completion date September 15, 2023

Study information

Verified date September 2022
Source Centre Hospitalier Universitaire de Besancon
Contact Damien GABRIEL, PhD
Phone +33 3 81 21 91 48
Email dgabriel@chu-besancon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this project is to help individuals better self-assess by taking advantage of their emotional feelings.


Description:

All emotions such as sadness, anger, fear or joy undoubtedly have an important place in our lives. Our emotions influence all areas of our lives and particularly our relationships: with our spouses, our friends, our children, our colleagues. Emotions are necessary for our decisions. By influencing our decisions, emotions automatically impact our performance. By guiding our choices, our emotions lead us to take risks. Taking risks is sometimes essential to a suitable decision. But this risk-taking must not result from an inappropriate decision-making process. People must therefore adapt their risk-taking, i.e. integrate our emotions into decision-making. It is therefore not a question of ignoring one's emotions, but of regulating them in order to be in a state favorable to action. This awareness of emotional feelings would help develop the ability to produce good internal feedback. The purpose of COSMOS project is to help individuals better self-assess by taking advantage of their emotional feelings. To do this, investigators will teach individuals to detect and manage their emotions using an emotional neurofeedback device developped by the Neuraxess platform (a functional neuroimiaging and neurostimulation platform, located in Besancon, France). Neurofeedback is a type of biofeedback, namely a rehabilitation method based on the subject's awareness of physiological processes, during which the neuronal activity of an individual is measured and presented to him in real time, here in artistic form. The goal of this method is that the individual manages to self-regulate his neuronal activity supposed to underlie a specific behavior. So, over time, the participant might be able to learn how to voluntarily control the activation of their cerebral cortex in order to regulate their emotions and behaviors in everyday life. Here, by learning to detect and manage their emotions, participants will be able to take more appropriate risks. The balloon test (Balloon Analogue Risk Task or BART) is used to measure risk taking. This tasks consists of inflating a balloon by clicking on a button on the computer. The more the balloon inflates, the more money participants earn, but the involved risk is to reach a threshold where the balloon bursts and participants lose everything. Participants have the choice between reaching the limit and losing everything or controlling ourselves and recovering our gains before the disaster. This is a simple test but it closely matches the behavior of the player at a poker or roulette table in a casino. Participants' risk-taking will be assessed before the emotional neurofeedback sessions and then after 10 sessions.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date September 15, 2023
Est. primary completion date July 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Subjects between 18 and 80 years old - Right-handed - Signed informed Consent Form - Subject affiliated to or beneficing from a French social security regime Exclusion Criteria: - Subjects under 18 years old and over 80 years old - Left-handed - Pregnant woman - Subject beneficiary from a legal protection regime - Subject unlikely to cooperate or low cooperation stated by investigator - Subject not covered by social security - Subject being in the exclusion period of another study or provided for by the "National Volunteer File"

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Neurofeedback + BART/EEG
10 sessions of emotional neurofeedback (max of 2 sessions per week and max of 10 weeks). Before (Baseline, Day 0) and at the study completion (after 10 neurofeedback sessions, Week 5), a EEG record is realized during the BART, assessing risk-taking behavior.
BART/EEG only
only the twice EEG record are realized during the BART, assessing risk-taking behavior (every corresponding to the pre and post-neurofeedback evaluations in arm I)

Locations

Country Name City State
France CHU Besancon - Clinical Psychiatric Department Besancon

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Besancon Plateforme Neuraxess

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in number of blue balloons adjusted with Balloon Analogue Risk Task [BART] Number of blue balloons adjusted with BART after 10 neurofeedback sessions among participants who received the neurofeedback treatment. Baseline (Day 0), at the study completion (after 10 neurofeedback sessions, Week 5)
Secondary Change in EPs during BART Amplitude variation of evoked potentials (EPs) detected by electroencephalography (EEG) during the Balloon Analogue Risk Task (BART), assessing risk-taking behavior. Variation will be obtained by comparing records before and after 10 neurofeedback sessions Baseline (Day 0), at the study completion (after 10 neurofeedback sessions, Week 5)
Secondary Feasibility of controlling brain activity during neurofeedback sessions Satisfaction assessed by a visual analogue scale (items: "I enjoyed participating in the experiment" ; "I was motivated during the experience" ; "I managed to control the particles by thought" and "I feel more relaxed after session". Baseline (Day 0), immediately after each neurofeedback sessions (session 1 to session 10) and at the study completion (after 10 neurofeedback sessions, Week 5)
Secondary Change in BIS-10 scores Compared scores from the French version of the Barratt Impulsiveness Scale (BIS-10). The French version of the BIS-10 is a self-rated 34 item questionnaire, composed by three subscales: motor-impulsivity, cognitive-impulsivity and non-planning-impulsivity. Each item is scored on a 0 to 4 points scale. Higher scores indicate higher levels of impulsivity. Baseline (Day 0), at the study completion (after 10 neurofeedback sessions, Week 5)
Secondary Change in MCQ scores Compared scores from the French version of the Monetary Choice Questionnaire (MCQ). The MCQ is a self-rated 27 item questionnaire which assessed the discounting. Delay discounting is the decline in the present value of a reward with delay to its receipt.
Example item: " Would you prefer 25€ today or 75€ in 15 days? " For each item, subjects must choose between a low immediate reward and a higher delayed reward.
Waiting times vary from 7 days to 186 days, and rewards are divided into 3 magnitudes: low (25-35€), medium (50-60€), high (75-85€).
This will allow assessing: the influence of the the magnitude of the difference between the two rewards proposed, the impact of the time on the reward's subjective value (speed at which the reward is devalued over time), reflected in the k index.
This index is calculated separately for each magnitude, and an average index is calculated for each subject.
The more the k index is high, the more the subject is considered impulsive.
Baseline (Day 0), at the study completion (after 10 neurofeedback sessions, Week 5)
See also
  Status Clinical Trial Phase
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Completed NCT05543811 - The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology N/A
Completed NCT04558411 - Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students N/A
Completed NCT03124446 - Mindfulness-Based College: Stage 1 N/A
Recruiting NCT04733300 - Online Mindfulness-Based College for Young Adults N/A
Completed NCT06085391 - Testing the Efficacy of the REThink Emotions Platform in a Full-scale SMART Study N/A
Completed NCT05080647 - Examining the Impacts of Parent Mightier Play N/A
Completed NCT05027113 - App-Based Mindfulness Meditation for People of Color Who Experience Race-Related Stress N/A
Completed NCT04536935 - Mobile Mental Health Apps for Suicide Prevention N/A
Completed NCT05607784 - Education Program to Reduce Risky Behavior in Adolescents Ph I
Completed NCT04839861 - Examining the Impacts of Parent-Child Interactive Activities N/A
Completed NCT04942678 - The Impact of Therapy Dogs on Anxiety and Emotional Management in the Pediatric Emergency Department
Completed NCT02661880 - The Role of Music in Palliative Care: A Proposal for a Rural Based Initiative in Music Based Interventions N/A
Recruiting NCT06267521 - The STRENGTHEN Study N/A
Recruiting NCT06054412 - An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers N/A
Recruiting NCT05718427 - Effect of ASI on Sensory, Motor, Cognitive, Behavioral Skills and Social Participation in Children With ADHD N/A
Not yet recruiting NCT05531318 - Emotional Regulation in People With Co-occurring Posttraumatic Stress Disorder and Substance Use Disorder
Recruiting NCT05472545 - Dyadic Neurofeedback for Development of Healthy Emotion Regulation in Youth N/A
Recruiting NCT05022550 - Virtual-reality and Emotion Regulation in Violence-Exposed Youth N/A
Enrolling by invitation NCT05859126 - Maternal Choline Supplementation and Offspring Cognition in Adolescence N/A